Search results
This page contains information about Pfizer's scientific breakthroughs for patients across multiple therapeutic areas in 2021, spotlights on noteworthy Pfizer colleagues and Bold Moves update charting how Pfizer is progressing toward its purpose of breakthroughs that change patients' lives.
- From Our CEO
2021 was a watershed year for Pfizer. A year in which we set...
- 2021 Stories
This page contains information about Pfizer's most important...
- Performance
in Pfizer’s 2021 Annual Report on Form 10-K for an...
- ESG
This page contains information about Pfizer’s approach to...
- Read More
Wilson disease may be rare, but its impact can be...
- Pfizer Works Toward Equitable and Affordable Access to Covid-19 Vaccines and Treatments Around The World
In November 2021, Pfizer and the Medicines Patent Pool...
- Pfizer Launches Breakthrough Fellowship Program
Fellows were supported by a “triad” of Pfizer colleagues...
- About This Review
This review covers Pfizer’s worldwide business and provides...
- From Our CEO
Pfizer Inc. is a research-based, global biopharmaceutical company.We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture and distribution of healthcare products, including innovative medicines and vaccines.
4 Pfizer 2022 Annual Review A Letter from Our Chairman & CEO To Our Shareholders A little more than four years ago, Pfizer unveiled a new purpose: Breakthroughs that change patients’ lives. Pfizer has always had a noble purpose rooted in our commitment to patients, but we wanted to make our purpose more memorable, more inspiring and, most ...
Discussion and Analysis of Financial Condition and Results of Operations in Pfizer’s 2021 Annual Report on Form 10-K for an explanation of how management uses these non-GAAP measures, reconciliations to the most directly comparable GAAP measures and additional information.
Upjohn Business Pfizer’s former global, primarily off-patent branded and generics business, which included a portfolio of 20 globally recognized solid oral dose brands, including Lipitor, Lyrica, Norvasc, Celebrex and Viagra, as well as
DOCUMENTS INCORPORATED BY REFERENCE Portions of the Proxy Statement for the 2023 Annual Meeting of Shareholders Part III. TABLE OF CONTENTS Page ... Unless the context requires otherwise, references to “Pfizer,” “the Company,” “we,” “us” or “our” in this Form 10-K (defined below) refer to Pfizer Inc. and its subsidiaries. ...
COVID-19 Updates. Read the latest information about Pfizer’s COVID-19 vaccine on Pfizer.com. Visit Pfizer.com. Downloads. Pfizer 2020 Annual Review. Performance Data. Pfizer 2020 ESG Report. Join the Conversation. Additional Information. About This Review. Corporate Shareholder Information. Pfizer 2020 Annual review.